Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel.
Widimsky P, Motovska Z, Bolognese L, Dudek D, Hamm C, Tanguay JF, Ten Berg J, Brown E, LeNarz L, Miller DL, Montalescot G; ACCOAST Investigators. Widimsky P, et al. Among authors: tanguay jf. Heart. 2015 Aug;101(15):1219-24. doi: 10.1136/heartjnl-2015-307686. Epub 2015 Jun 9. Heart. 2015. PMID: 26060122 Clinical Trial.
Effect on bleeding, time to revascularization, and one-year clinical outcomes of the radial approach during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Arzamendi D, Ly HQ, Tanguay JF, Chan MY, Chevallereau P, Gallo R, Ibrahim R, L'Allier P, Levesque S, Gosselin G, Deguise P, Joyal M, Gregoire J, Bonan R, Crepeau J, Doucet S. Arzamendi D, et al. Among authors: tanguay jf. Am J Cardiol. 2010 Jul 15;106(2):148-54. doi: 10.1016/j.amjcard.2010.02.028. Am J Cardiol. 2010. PMID: 20598995
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Di Pasquale G, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KA, Yusuf S; CURRENT-OASIS 7 trial investigators. Mehta SR, et al. Among authors: tanguay jf. Lancet. 2010 Oct 9;376(9748):1233-43. doi: 10.1016/S0140-6736(10)61088-4. Lancet. 2010. PMID: 20817281 Clinical Trial.
Increase in sudden death from coronary artery disease in young adults.
Arzamendi D, Benito B, Tizon-Marcos H, Flores J, Tanguay JF, Ly H, Doucet S, Leduc L, Leung TK, Campuzano O, Iglesias A, Talajic M, Brugada R. Arzamendi D, et al. Among authors: tanguay jf. Am Heart J. 2011 Mar;161(3):574-80. doi: 10.1016/j.ahj.2010.10.040. Am Heart J. 2011. PMID: 21392614
A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study.
Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF, ten Berg J, Widimsky P, Luo J, Miller DL, Goedicke J. Montalescot G, et al. Among authors: tanguay jf. Am Heart J. 2011 Apr;161(4):650-656.e1. doi: 10.1016/j.ahj.2010.10.017. Epub 2011 Feb 25. Am Heart J. 2011. PMID: 21473962 Clinical Trial.
Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
Arzamendi D, Ly HQ, Tanguay JF, Armero S, Jilaihawi H, Gallo R, Ibrahim R, L'Allier P, Blondeau L, Gosselin G, Gregoire J, Doucet S. Arzamendi D, et al. Among authors: tanguay jf. Catheter Cardiovasc Interv. 2013 Aug 1;82(2):193-200. doi: 10.1002/ccd.23300. Epub 2013 May 7. Catheter Cardiovasc Interv. 2013. PMID: 21805615
246 results